0001209191-23-010936.txt : 20230217 0001209191-23-010936.hdr.sgml : 20230217 20230217202215 ACCESSION NUMBER: 0001209191-23-010936 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230215 FILED AS OF DATE: 20230217 DATE AS OF CHANGE: 20230217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Healey Don CENTRAL INDEX KEY: 0001643067 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38359 FILM NUMBER: 23644906 MAIL ADDRESS: STREET 1: 2635 TECHNOLOGY FOREST BOULEVARD CITY: THE WOODLANDS STATE: TX ZIP: 77381 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adicet Bio, Inc. CENTRAL INDEX KEY: 0001720580 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813305277 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 BERKELEY STREET STREET 2: 19TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-482-2333 MAIL ADDRESS: STREET 1: 200 BERKELEY STREET STREET 2: 19TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: resTORbio, Inc. DATE OF NAME CHANGE: 20171024 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-15 0 0001720580 Adicet Bio, Inc. ACET 0001643067 Healey Don C/O ADICET BIO, INC. 200 BERKELEY STREET, 19TH FLOOR BOSTON MA 02116 0 1 0 0 Chief Technology Officer Common Stock 2023-02-15 4 S 0 4533 7.5726 D 66568 D The sales reported in this Form 4 were effected to fund tax obligations related to PSUs and RSUs that vested in 2022 pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 11, 2023. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $7.43 to $7.72, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Securities and Exchange Commission staff upon request. /s/ Nick Harvey, Attorney-in-Fact 2023-02-17